BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 28855578)

  • 1. HuR-targeted small molecule inhibitor exhibits cytotoxicity towards human lung cancer cells.
    Muralidharan R; Mehta M; Ahmed R; Roy S; Xu L; Aubé J; Chen A; Zhao YD; Herman T; Ramesh R; Munshi A
    Sci Rep; 2017 Aug; 7(1):9694. PubMed ID: 28855578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The HuR CMLD-2 inhibitor exhibits antitumor effects via MAD2 downregulation in thyroid cancer cells.
    Allegri L; Baldan F; Roy S; Aubé J; Russo D; Filetti S; Damante G
    Sci Rep; 2019 May; 9(1):7374. PubMed ID: 31089242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folate receptor-targeted nanoparticle delivery of HuR-RNAi suppresses lung cancer cell proliferation and migration.
    Muralidharan R; Babu A; Amreddy N; Basalingappa K; Mehta M; Chen A; Zhao YD; Kompella UB; Munshi A; Ramesh R
    J Nanobiotechnology; 2016 Jun; 14(1):47. PubMed ID: 27328938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-targeted Nanoparticle Delivery of HuR siRNA Inhibits Lung Tumor Growth
    Muralidharan R; Babu A; Amreddy N; Srivastava A; Chen A; Zhao YD; Kompella UB; Munshi A; Ramesh R
    Mol Cancer Ther; 2017 Aug; 16(8):1470-1486. PubMed ID: 28572169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticancer effects of ginsenoside Rk3 on non-small cell lung cancer cells: in vitro and in vivo.
    Duan Z; Deng J; Dong Y; Zhu C; Li W; Fan D
    Food Funct; 2017 Oct; 8(10):3723-3736. PubMed ID: 28949353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MUC16 promotes triple-negative breast cancer lung metastasis by modulating RNA-binding protein ELAVL1/HUR.
    Chaudhary S; Appadurai MI; Maurya SK; Nallasamy P; Marimuthu S; Shah A; Atri P; Ramakanth CV; Lele SM; Seshacharyulu P; Ponnusamy MP; Nasser MW; Ganti AK; Batra SK; Lakshmanan I
    Breast Cancer Res; 2023 Mar; 25(1):25. PubMed ID: 36918912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Silencing of the mRNA-binding protein HuR increases the sensitivity of colorectal cancer cells to ionizing radiation through upregulation of caspase-2.
    Badawi A; Hehlgans S; Pfeilschifter J; Rödel F; Eberhardt W
    Cancer Lett; 2017 May; 393():103-112. PubMed ID: 28219770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The RNA Binding Protein HuR: A Promising Drug Target for Anticancer Therapy.
    Wu M; Tong CWS; Yan W; To KKW; Cho WCS
    Curr Cancer Drug Targets; 2019; 19(5):382-399. PubMed ID: 30381077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting apoptosis by 1,2-diazole through regulation of EGFR, Bcl-2 and CDK-2 mediated signaling pathway in human non-small cell lung carcinoma A549 cells.
    Vinod Prabhu V; Elangovan P; Niranjali Devaraj S; Sakthivel KM
    Gene; 2018 Dec; 679():352-359. PubMed ID: 30218747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cephalochromin induces G0/G1 cell cycle arrest and apoptosis in A549 human non-small-cell lung cancer cells by inflicting mitochondrial disruption.
    Hsiao CJ; Hsiao G; Chen WL; Wang SW; Chiang CP; Liu LY; Guh JH; Lee TH; Chung CL
    J Nat Prod; 2014 Apr; 77(4):758-65. PubMed ID: 24588135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human antigen R mediated post-transcriptional regulation of inhibitors of apoptosis proteins in pancreatic cancer.
    Lukosiute-Urboniene A; Jasukaitiene A; Silkuniene G; Barauskas V; Gulbinas A; Dambrauskas Z
    World J Gastroenterol; 2019 Jan; 25(2):205-219. PubMed ID: 30670910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased human antigen R expression confers resistance to tyrosine kinase inhibitors in epidermal growth factor receptor-mutant lung cancer by inhibiting Bim expression.
    Yao Y; Chu H; Wang J; Wang B
    Int J Mol Med; 2018 Nov; 42(5):2930-2942. PubMed ID: 30226552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of reactive oxygen species-mediated ERK and JNK activation sensitizes dihydromyricetin-induced mitochondrial apoptosis in human non-small cell lung cancer.
    Kao SJ; Lee WJ; Chang JH; Chow JM; Chung CL; Hung WY; Chien MH
    Environ Toxicol; 2017 Apr; 32(4):1426-1438. PubMed ID: 27539140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Posttranscriptional Regulation of Human Antigen R by miR-133b Enhances Docetaxel Cytotoxicity Through the Inhibition of ATP-Binding Cassette Subfamily G Member 2 in Prostate Cancer Cells.
    Liu H; Song X; Hou J; Zhao Z; Chang J
    DNA Cell Biol; 2018 Mar; 37(3):210-219. PubMed ID: 29327946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth arrest and apoptosis via caspase activation of dioscoreanone in human non-small-cell lung cancer A549 cells.
    Hansakul P; Aree K; Tanuchit S; Itharat A
    BMC Complement Altern Med; 2014 Oct; 14():413. PubMed ID: 25342427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 7-O-geranylquercetin-induced autophagy contributes to apoptosis via ROS generation in human non-small cell lung cancer cells.
    Wang EX; Zou BY; Shi L; Du LY; Zhu YY; Jiang YM; Ma XD; Kang XH; Wang CY; Zhen YH; Sun LD
    Life Sci; 2017 Jul; 180():102-113. PubMed ID: 28495516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. UBE4B regulates p27 expression in A549 NSCLC cells through regulating the interaction of HuR and the p27 5' UTR.
    Kim H; Jung SY; Yun HH; Yoo K; Lee JS; Lee JH
    Biochem Biophys Res Commun; 2024 Feb; 695():149484. PubMed ID: 38211530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An RNA-Binding Protein, Hu-antigen R, in Pancreatic Cancer Epithelial to Mesenchymal Transition, Metastasis, and Cancer Stem Cells.
    Dong R; Chen P; Polireddy K; Wu X; Wang T; Ramesh R; Dixon DA; Xu L; Aubé J; Chen Q
    Mol Cancer Ther; 2020 Nov; 19(11):2267-2277. PubMed ID: 32879054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel epidermal growth factor receptor inhibitor promotes apoptosis in non-small cell lung cancer cells resistant to erlotinib.
    de La Motte Rouge T; Galluzzi L; Olaussen KA; Zermati Y; Tasdemir E; Robert T; Ripoche H; Lazar V; Dessen P; Harper F; Pierron G; Pinna G; Araujo N; Harel-Belan A; Armand JP; Wong TW; Soria JC; Kroemer G
    Cancer Res; 2007 Jul; 67(13):6253-62. PubMed ID: 17616683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apigenin potentiates TRAIL therapy of non-small cell lung cancer via upregulating DR4/DR5 expression in a p53-dependent manner.
    Chen M; Wang X; Zha D; Cai F; Zhang W; He Y; Huang Q; Zhuang H; Hua ZC
    Sci Rep; 2016 Oct; 6():35468. PubMed ID: 27752089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.